You are here:
Two key factors set the GAVI Alliance apart from other actors in the field of international health aid:
In this section, we explain GAVI’s unique business model and the six ways it delivers "added value".
Donor and developing countries need to see proof of the value of new vaccines before investing.
Immunisation is a commitment for life that requires guaranteed, long-term funding.
Developing countries decide for themselves how best to use GAVI support for immunisation.
It's not enough to buy new vaccines. They have to safely reach every child.
Manufacturers will only make vaccines for poor countries if they know they can sell them .
National immunisation programes must survive long after GAVI support stops.
The Accelerated Vaccine Introduction Initiative is a showcase of the GAVI business model at work.
Approximately six million future deaths averted from hepatitis B, Haemophilus influenzae type B, measles, pertussis, pneumococcal disease, polio, rotavirus diarrhoea and yellow fever since GAVI's launch in 2000.
© GAVI Alliance 2013
modal window here